Physician profile
Joel R Tuite
NPI 1912107285
$512.99
in general payments reported to CMS, 2019-2025
5 companies · $26.70 in 2025
The $26.70 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110 · 2020: $55.68 · 2021: $38.80 · 2022: $63.90 · 2023: $148 · 2024: $70.31 · 2025: $26.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $244.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $208.91 | 2022-2025 | Vuity, Lumigan, Alphagan P |
| Allergan, INC. | $124.03 | 2019-2022 | |
| Coopervision INC. | $112.02 | 2020-2024 | Biofinity Contact Lens, Myday Contact Lens |
| Optovue, INC. | $41.89 | 2020 | |
| Bausch & Lomb Americas INC. | $26.14 | 2024 | Miebo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Tuite listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.